|Application ||WB, FC, E|
|Calculated MW||30850 Da|
|Antigen Region||195-224 aa|
|Other Names||Carbonyl reductase [NADPH] 3, NADPH-dependent carbonyl reductase 3, CBR3|
|Target/Specificity||This CBR3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 195-224 amino acids from the C-terminal region of human CBR3.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||CBR3 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Has low NADPH-dependent oxidoreductase activity towards 4-benzoylpyridine and menadione (in vitro).|
|Tissue Location||Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Carbonyl reductase 3 catalyzes the reduction of a large number of biologically and pharmacologically active carbonyl compounds to their corresponding alcohols. The enzyme is classified as a monomeric NADPH-dependent oxidoreductase. CBR3 contains three exons spanning 11.2 kilobases and is closely linked to another carbonyl reductase gene - CBR1.
Guey, L.T., et al. Eur. Urol. 57(2):283-292(2010)
Hosgood, H.D. III, et al. Respir Med 103(12):1866-1870(2009)
Zhang, J., et al. Pharm. Res. 26(9):2209-2215(2009)
Choi, J.Y., et al. Clin. Cancer Res. 15(16):5258-5266(2009)
Pilka, E.S., et al. PLoS ONE 4 (10), E7113 (2009) :
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.